258 related articles for article (PubMed ID: 31622687)
1. IκBζ is a key player in the antipsoriatic effects of secukinumab.
Bertelsen T; Ljungberg C; Litman T; Huppertz C; Hennze R; Rønholt K; Iversen L; Johansen C
J Allergy Clin Immunol; 2020 Jan; 145(1):379-390. PubMed ID: 31622687
[TBL] [Abstract][Full Text] [Related]
2. IκBζ is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes.
Müller A; Hennig A; Lorscheid S; Grondona P; Schulze-Osthoff K; Hailfinger S; Kramer D
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10088-10093. PubMed ID: 30224457
[TBL] [Abstract][Full Text] [Related]
3. The human IL-17A/F heterodimer regulates psoriasis-associated genes through IκBζ.
Bertelsen T; Iversen L; Johansen C
Exp Dermatol; 2018 Sep; 27(9):1048-1052. PubMed ID: 29938836
[TBL] [Abstract][Full Text] [Related]
4. IL-17F regulates psoriasis-associated genes through IκBζ.
Bertelsen T; Ljungberg C; Boye Kjellerup R; Iversen L; Johansen C
Exp Dermatol; 2017 Mar; 26(3):234-241. PubMed ID: 27576147
[TBL] [Abstract][Full Text] [Related]
5. IkBζ is a Key Regulator of Tumour Necrosis Factor-a and Interleukin-17A-mediated Induction of Interleukin-36g in Human Keratinocytes.
Ovesen SK; Schulze-Osthoff K; Iversen L; Johansen C
Acta Derm Venereol; 2021 Feb; 101(2):adv00386. PubMed ID: 33491092
[TBL] [Abstract][Full Text] [Related]
6. IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytes.
Muromoto R; Hirao T; Tawa K; Hirashima K; Kon S; Kitai Y; Matsuda T
Int Immunol; 2016 Sep; 28(9):443-52. PubMed ID: 26944069
[TBL] [Abstract][Full Text] [Related]
7. I-Kappa-B-Zeta Regulates Interleukin-17A/Tumor Necrosis Factor-Alpha Mediated Synergistic Induction of Interleukin-19 and Interleukin-20 in Humane Keratinocytes.
Bertelsen T; Iversen L; Johansen C
Ann Dermatol; 2021 Apr; 33(2):122-130. PubMed ID: 33935453
[TBL] [Abstract][Full Text] [Related]
8. Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by down-regulating IκBζ.
Tu J; Yin Z; Guo J; He F; Long F; Yin Z
Int Immunopharmacol; 2020 Feb; 79():106045. PubMed ID: 31863918
[TBL] [Abstract][Full Text] [Related]
9. Characterization of TNF-α- and IL-17A-Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ.
Johansen C; Bertelsen T; Ljungberg C; Mose M; Iversen L
J Invest Dermatol; 2016 Aug; 136(8):1608-1616. PubMed ID: 27117051
[TBL] [Abstract][Full Text] [Related]
10. IκBζ is a key driver in the development of psoriasis.
Johansen C; Mose M; Ommen P; Bertelsen T; Vinter H; Hailfinger S; Lorscheid S; Schulze-Osthoff K; Iversen L
Proc Natl Acad Sci U S A; 2015 Oct; 112(43):E5825-33. PubMed ID: 26460049
[TBL] [Abstract][Full Text] [Related]
11. CUX1 and IκBζ (NFKBIZ) mediate the synergistic inflammatory response to TNF and IL-17A in stromal fibroblasts.
Slowikowski K; Nguyen HN; Noss EH; Simmons DP; Mizoguchi F; Watts GFM; Gurish MF; Brenner MB; Raychaudhuri S
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5532-5541. PubMed ID: 32079724
[TBL] [Abstract][Full Text] [Related]
12. A novel role of IL-17A in contributing to the impaired suppressive function of Tregs in psoriasis.
Liu Y; Zhang C; Li B; Yu C; Bai X; Xiao C; Wang L; Dang E; Yang L; Wang G
J Dermatol Sci; 2021 Feb; 101(2):84-92. PubMed ID: 33334656
[TBL] [Abstract][Full Text] [Related]
13. IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis.
Krueger JG; Wharton KA; Schlitt T; Suprun M; Torene RI; Jiang X; Wang CQ; Fuentes-Duculan J; Hartmann N; Peters T; Koroleva I; Hillenbrand R; Letzkus M; Yu X; Li Y; Glueck A; Hasselberg A; Flannery B; Suárez-Fariñas M; Hueber W
J Allergy Clin Immunol; 2019 Sep; 144(3):750-763. PubMed ID: 31129129
[TBL] [Abstract][Full Text] [Related]
14. IL-17A synergistically enhances TLR3-mediated IL-36γ production by keratinocytes: A potential role in injury-amplified psoriatic inflammation.
Liu S; Wu F; Wu Z; Li Y; Zhang S; Yu N
Exp Dermatol; 2019 Mar; 28(3):233-239. PubMed ID: 30614571
[TBL] [Abstract][Full Text] [Related]
15. IκBζ: A key protein in the pathogenesis of psoriasis.
Johansen C
Cytokine; 2016 Feb; 78():20-1. PubMed ID: 26615569
[TBL] [Abstract][Full Text] [Related]
16. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.
Johansen C; Vinter H; Soegaard-Madsen L; Olsen LR; Steiniche T; Iversen L; Kragballe K
Br J Dermatol; 2010 Dec; 163(6):1194-204. PubMed ID: 20846304
[TBL] [Abstract][Full Text] [Related]
17. Nfkbiz regulates the proliferation and differentiation of keratinocytes.
Ishiguro-Oonuma T; Ochiai K; Hashizume K; Iwanaga T; Morimatsu M
Jpn J Vet Res; 2015 Aug; 63(3):107-14. PubMed ID: 26563030
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte-derived IκBζ drives psoriasis and associated systemic inflammation.
Lorscheid S; Müller A; Löffler J; Resch C; Bucher P; Kurschus FC; Waisman A; Schäkel K; Hailfinger S; Schulze-Osthoff K; Kramer D
JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31622280
[TBL] [Abstract][Full Text] [Related]
19. Induction of IκBζ Augments Cytokine and Chemokine Production by IL-33 in Mast Cells.
Ohto-Ozaki H; Hayakawa M; Kamoshita N; Maruyama T; Tominaga SI; Ohmori T
J Immunol; 2020 Apr; 204(8):2033-2042. PubMed ID: 32144162
[TBL] [Abstract][Full Text] [Related]
20. EGFR ligands synergistically increase IL-17A-induced expression of psoriasis signature genes in human keratinocytes via IκBζ and Bcl3.
Dai X; Murakami M; Shiraishi K; Muto J; Tohyama M; Mori H; Utsunomiya R; Sayama K
Eur J Immunol; 2022 Jun; 52(6):994-1005. PubMed ID: 35411943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
